Authorised

Product identification

Medicine name:
Rabisin Vet. injektionsvæske, suspension
Rabisin Vet. injektionsvæske, suspension
Active substance:
  • Rabies virus, strain G52, Inactivated
Target species:
  • Cat
  • Cattle
  • Dog
  • Sheep
  • Horse
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Rabies virus, strain G52, Inactivated
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
    • Cattle
    • Dog
    • Sheep
    • Horse
  • Intramuscular use
    • Cattle
    • Dog
    • Sheep
    • Horse
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Denmark A/S
Marketing authorisation date:
Manufacturing sites for batch release:
  • Merial
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 09961
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, INJEKTIONSVÆSKE, SUSPENSION)
Published on: 29/06/2023

Source URL: https://medicines.health.europa.eu/veterinary/600000055659